Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Scientists have identified a possible reason the AstraZeneca Plc's (NASDAQ:AZN) COVID-19 vaccine may cause blood clots after the use of the shot was limited to prevent the rare side effect.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- The preclinical research conducted with AstraZeneca found that the interaction between the vaccine and a protein known as platelet factor 4 could be behind the cases of thrombosis with thrombocytopenia syndrome.
- The study was published in the journal Science Advances by scientists from U.S. and U.K. universities and AstraZeneca. The research is not definitive, the company said.
- The vaccine, co-developed with the University of Oxford, has been hampered by a possible link between the shot and rare cases of blood clots.
- The U.K. limited its use to those over 40 years, and the U.S. has yet to authorize the vaccine.
- Related Link: Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots.
- "Although the research is not definitive, it offers interesting insights, and AstraZeneca is exploring ways to leverage these findings as part of our efforts to remove this extremely rare side effect," the company said in a statement.
- The company highlighted that the mechanism identified does not demonstrate it is the cause of the rare thrombosis, and most individuals who have PF4 antibodies will not develop clots.
- Also See: No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study Shows.
- Price Action: AZN shares are down 0.13% at $53.81 during the market session on the last check Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.